Arcadia Biosciences GAAP EPS of $0.63 beats by $1.29, revenue of $1.3M misses by $0.1M

* Arcadia Biosciences press release [https://seekingalpha.com/pr/20299415-arcadia-biosciences-rkda-announces-third-quarter-2025-financial-results-and-business] (RKDA [https://seekingalpha.com/symbol/RKDA]): Q3 GAAP EPS of $0.63 beats by $1.29.
* Revenue of $1.3M (-15.6% Y/Y) misses by $0.1M.
* _Zola__®__ year-to-date revenues increase 26% year over year._
* _Arcadia gross profit margins exceed 30% for 11__th__ straight quarter._
* _Arcadia cash balance declines by only $257K to $1.1M._

MORE ON ARCADIA BIOSCIENCES

* Seeking Alpha’s Quant Rating on Arcadia Biosciences [https://seekingalpha.com/symbol/RKDA/ratings/quant-ratings]
* Historical earnings data for Arcadia Biosciences [https://seekingalpha.com/symbol/RKDA/earnings]
* Financial information for Arcadia Biosciences [https://seekingalpha.com/symbol/RKDA/income-statement]